Biomarkers to guide medical therapy in primary aldosteronism

GL Hundemer, AA Leung, GA Kline… - Endocrine …, 2024 - academic.oup.com
Primary aldosteronism (PA) is an endocrinopathy characterized by dysregulated
aldosterone production that occurs despite suppression of renin and angiotensin II, and that …

Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks

N Mullen, J Curneen, PT Donlon, P Prakash… - Endocrine …, 2024 - academic.oup.com
Primary aldosteronism (PA) is the most common cause of secondary hypertension and is
associated with increased morbidity and mortality when compared with blood pressure …

Approach to the patient on antihypertensive therapy: screen for primary aldosteronism

P Mulatero, C Bertello, F Veglio… - The Journal of Clinical …, 2022 - academic.oup.com
Primary aldosteronism (PA) is a condition that is still largely overlooked, resulting in a
considerable burden of mortality and morbidity. This is despite decades of clinical and …

Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review

A Januszewicz, P Mulatero, P Dobrowolski… - Journal of the American …, 2022 - jacc.org
Several forms of secondary hypertension carry a high risk of cardiac morbidity and mortality.
Evaluation of cardiac phenotypes in secondary hypertension provides a unique opportunity …

Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis

S Samnani, I Cenzer, GA Kline, SJ Lee… - The Journal of …, 2024 - academic.oup.com
Context Primary aldosteronism (PA) is one of the most common causes of secondary
hypertension, but the comparative outcomes of targeted treatment remain unclear …

Molecular and epigenetic control of aldosterone synthase, CYP11B2 and 11-Hydroxylase, CYP11B1

Y Takeda, M Demura, M Kometani… - International journal of …, 2023 - mdpi.com
Aldosterone and cortisol serve important roles in the pathogenesis of cardiovascular
diseases and metabolic disorders. Epigenetics is a mechanism to control enzyme …

Differential role of aldosterone and transforming growth factor beta-1 in cardiac remodeling

P Kmieć, S Rosenkranz, M Odenthal… - International Journal of …, 2023 - mdpi.com
Angiotensin II, a major culprit in cardiovascular disease, activates mediators that are also
involved in pathological cardiac remodeling. In this context, we aimed at investigating the …

Long-term follow-up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: the progression of primary aldosteronism phenotypes

F Buffolo, A Pecori, M Reincke, M Outland, F Veglio… - …, 2024 - Am Heart Assoc
BACKGROUND: About 10% of patients with arterial hypertension have a positive screening
test for primary aldosteronism (PA) and 50% to 70% of them have a negative confirmatory …

Relevance of KCNJ5 in Pathologies of Heart Disease

KM Meyer, N Malhotra, J Kwak… - International journal of …, 2023 - mdpi.com
Abnormalities in G-protein-gated inwardly rectifying potassium (GIRK) channels have been
implicated in diseased states of the cardiovascular system; however, the role of GIRK4 (Kir3 …

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism

Y Zhou, X Wang, J Hou, J Wan, Y Yang, S Liu… - Hypertension …, 2024 - nature.com
Our prior study has suggested that percutaneous superselective adrenal arterial
embolization (SAAE) with ethanol reduces blood pressure in patients with primary …